How Parkinson’s genetics is transforming drug development

News

Author: Parkinson's Life editorsPublished: 15 February 2017

Prep: Cook: Serves:

This month’s free webinar from the Michael J Fox Foundation will discuss genetic mutations associated with Parkinson’s and how this understanding could help develop and test therapies

‘Parkinson’s Genetics: How What We’re Learning Is Transforming Drug Development’ is the title of the next instalment in the free Third Thursdays webinar series by the Michael J Fox Foundation and will broadcast on 16 February at 12:00 EST.

Hosted by journalist and principal moderator for Partners in Parkinson’s, Dave Iverson, this hour-long webinar invites experts to discuss the latest findings in the genetic element of Parkinson’s disease.

Although the incidence of receiving a Parkinson’s diagnosis that is a direct result of a genetic mutation is low, researchers can learn from the biology of people with this mutation – with and without Parkinson’s. This could lead to new therapies that have the potential to help all living with the condition.

The session will also discuss what is already known about genetic mutations associated with Parkinson’s and how this understanding is helping develop and test therapies that may slow or stop progression.

It’s free to join the live webinar, just register here up to 15 minutes before its start time at 12:00 EST on 16 February. Listeners can submit their own questions to the experts while the discussion is happening in real time. And if you can’t make it for the live broadcast, catch the recording in the library archive here.

Last Month

Next Month

Go Back

Share this story

Comments

Resources & Tools

Dealing with a diagnosis: a guide to Parkinson’s

A new guidebook offers peer-to-peer advice

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

Monika Dugar tells us about her project aiming to improve mobility

Growing stronger, day by day

How to stay positive by developing a 'growth mindset'

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

Could frailty be a potential risk factor for Parkinson’s disease?

Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

How Parkinson’s genetics is transforming drug development

News

Author: Parkinson's Life editorsPublished: 15 February 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Resources & Tools

Dealing with a diagnosis: a guide to Parkinson’s

Interviews

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

Health & Fitness

Growing stronger, day by day

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

How Parkinson’s genetics is transforming drug development

News

Author: Parkinson's Life editorsPublished: 15 February 2017

Last Month

Next Month

Share this story

Comments

Related articles

Resources & Tools

Dealing with a diagnosis: a guide to Parkinson’s

Interviews

Meet the fashion graduate designing adaptive clothing for people with Parkinson’s

Health & Fitness

Growing stronger, day by day

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Study explores predictors of cognitive impairment in Parkinson’s disease

Could frailty be a potential risk factor for Parkinson’s disease?

{title}

Subscribe

Sign in